Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve the Unaudited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has informed BSE that its Board of Directors will meet on August 7, 2025, to consider and approve the Unaudited Financial Results (both Standalone and Consolidated) for the quarter ended June 30, 2025. The company has also confirmed that the trading window for dealing in its securities will remain closed for designated persons and their immediate relatives until 48 hours after the results are disclosed to the stock exchange. This is a standard regulatory intimation under SEBI's Listing Obligations and Disclosure Requirements.
This is a routine procedural filing with no direct impact on shareholders. Investors should watch for the Q1 results to be released after August 7, 2025, which will provide insight into the company's quarterly performance.